Ardian, Sagemount, Eir, Thoma Bravo back life sciences software; 1315 Capital eyes value creation potential in Argonaut’s diagnostics division

Published on September 11, 2026

AI and regulatory complexity are driving demand for life sciences software, which in turn has attracted private equity; 1315 Capital closes a carve-out deal with a portfolio company of Telegraph Hill Partners and New Vale Capital.

The post Ardian, Sagemount, Eir, Thoma Bravo back life sciences software; 1315 Capital eyes value creation potential in Argonaut’s diagnostics division appeared first on PE Hub.

Continue reading on website
Other news

GSK Signs 500,000-Tonne Carbon Removal Deal with Varaha

September 11, 2026
Global biopharma company GSK announced that it has signed an eight-year agreement in with carbon removal project developer Varaha, for the purchase of more than 500,000 carbon credits generated from a project expanding regenerative agriculture practices in northern India. The agreement was structured by nature-focused investment platform Earthly.Founded in India in 2022, Varaha specializes in natu

Balcony solar is this year’s clean energy superstar in the US

September 11, 2026
This analysis and news roundup come from the Canary Media Weekly newsletter. Sign up to get it every Friday. Summer is only just coming to a close, but this year’s top clean energy trendsetter is already clear. At the start of 2026, you may never have even heard of balcony solar. The panels have long been staples…